New psychology program is both on campus and online for fall 2021
The Arizona State University Department of Psychology is launching a new on-ground and online Bachelor of Science degree in neuroscience this fall, designed to train the next generation of neuroscientists.
Twenty of Arizona’s highest-achieving high-school seniors have been awarded the prestigious Flinn Scholarship and will receive a full ride at one of the state’s public universities.
Now in its 36th year, the Flinn Scholars Program is supported by the Phoenix-based Flinn Foundation in partnership with Arizona’s three state universities. The merit-based scholarship covers the full cost of tuition, mandatory fees, housing, meals, study abroad, and many other exclusive opportunities—a package valued at more than $120,000.
As the country moves into a new phase of the vaccination effort – one where all adults are eligible for vaccinations – we want to ensure that you are aware of a new tax credit that President Biden announced today. The new paid leave tax credit will offset the cost for employers with fewer than 500 employees to provide full pay for when their employees get a COVID-19 vaccination or recover from that vaccination.
ROCHESTER, Minn. — A new Mayo Clinic study bolsters evidence that colorectal cancer is often imprinted in family genes and passed on from one generation to the next.
In the study, published in Clinical Gastroenterology and Hepatology, researchers within the Mayo Clinic Center for Individualized Medicine found 1 in 6 patients with colorectal cancer had an inherited cancer-related gene mutation, which likely predisposed them to the disease. In addition, the researchers discovered that 60% of these cases would not have been detected if relying on a standard guideline-based approach.
Serpass Biologics, Dr. Lucas’ startup, is developing a new class of immune-modulating biologics for autoimmune disorders. These can be used to treat and suppress excessive immune system responses in a wide range of diseases, including arthritic, cardiac, gastrointestinal, pulmonary and vascular disorders.
The annual competition is run by Skysong Innovations, which works across the university to help researchers pursue commercial applications for their work.
Talented team and industry-leading lab will help strengthen the company’s sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings.
Boosting ABCC1 could lessen the production of plaque linked to Alzheimer’s development
PHOENIX, Ariz. — April 13, 2021 — Findings of a study by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that increasing expression of a gene known as ABCC1 could not only reduce the deposition of a hard plaque in the brain that leads to Alzheimer’s disease, but might also prevent or delay this memory-robbing disease from developing.
– Trodelvy Significantly Reduced the Risk of Death by 49% Compared with Single-Agent Chemotherapy in the Phase 3 ASCENT Study –
– Trodelvy is Under Regulatory Review in the EU and in the United Kingdom, Canada, Switzerland and Australia as Part of Project Orbis –
Tempe, Ariz., April 8, 2021 – Arizona State University, through Skysong Innovations, continues to achieve high rankings in technology transfer metrics. The latest read on this is a survey by the Association of University Technology Managers (AUTM). According to AUTM’s most recent survey (fiscal year 2019), ASU was fourth in patents granted, fourth in startups companies launched and third in inventions disclosed when compared to other universities without a medical school.